StreetInsider.com News Articles

Form 4 Symbotic Inc. For: Oct 05 Filed by: KRASNOW TODD

Wed, 07 Oct 2026 20:43:00 -0400

si-local-file:///var/storage/secattach/20261007/27162315.html

Form 4 Symbotic Inc. For: Oct 01 Filed by: KANE CHARLES

Mon, 05 Oct 2026 21:23:00 -0400

si-local-file:///var/storage/secattach/20261005/27150563.html

Form 144 Symbotic Inc. Filed by: KANE CHARLES

Thu, 01 Oct 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20261001/27136559.html

Symbotic Inc. (SYM) PT Lowered to $60 at Needham

Tue, 15 Sep 2026 07:25:57 -0400

(Updated - September 15, 2026 7:25 AM EDT)

Needham analyst Robert Jamieson lowered the price target on Symbotic Inc. (NASDAQ: SYM) to $60.00 (from $75.00) while maintaining a Buy rating.

The analyst commented: "We are transferring coverage of Symbotic (SYM) from Jim Ricchiuti to Robert Jamieson. We reiterate our Buy rating and trim our price target to $60, from $75. Shares have lagged the broader market by ~41% YTD. Underperformance has been entirely driven by multiple compression. Shares are down ~30%, yet FY26 EBITDA estimates have been raised by ~28% since January 1st (FY27 estimates are up 15% over the same period).

Symbotic Inc. (SYM) PT Lowered to $60 at Needham

Tue, 15 Sep 2026 07:25:57 -0400

(Updated - September 15, 2026 7:25 AM EDT)

Needham analyst Robert Jamieson lowered the price target on Symbotic Inc. (NASDAQ: SYM) to $60.00 (from $75.00) while maintaining a Buy rating.

Form 4 Symbotic Inc. For: Sep 10 Filed by: Ladensohn David A

Mon, 14 Sep 2026 17:31:00 -0400

si-local-file:///var/storage/secattach/20260914/27059479.html

Form 4 Symbotic Inc. For: Sep 08 Filed by: KRASNOW TODD

Thu, 10 Sep 2026 19:22:00 -0400

si-local-file:///var/storage/secattach/20260910/27049736.html

Symbotic Inc. (SYM) PT Lowered to $38 at Barclays

Tue, 08 Sep 2026 07:54:42 -0400

Barclays analyst Guy Hardwick lowered the price target on Symbotic Inc. (NASDAQ: SYM) to $38.00 (from $44.00) while maintaining a Underweight rating.

Form 4 Symbotic Inc. For: Aug 26 Filed by: Ross Andrew D

Fri, 28 Aug 2026 19:01:00 -0400

si-local-file:///var/storage/secattach/20260828/26999335.html

Form 4 Symbotic Inc. For: Aug 26 Filed by: Ross Andrew D

Fri, 28 Aug 2026 19:01:00 -0400

si-local-file:///var/storage/secattach/20260828/26999335.html

Form 144 Symbotic Inc. Filed by: Dunn Michael David

Wed, 26 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260826/26982007.html

Form 144 Symbotic Inc. Filed by: Dunn Michael David

Wed, 26 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260826/26982007.html

Form 4 Symbotic Inc. For: Aug 23 Filed by: Kuffner James

Tue, 25 Aug 2026 20:04:00 -0400

si-local-file:///var/storage/secattach/20260825/26976097.html

Form 4 Symbotic Inc. For: Aug 23 Filed by: Kuffner James

Tue, 25 Aug 2026 20:04:00 -0400

si-local-file:///var/storage/secattach/20260825/26976097.html

Grabar Law Office Investigates Claims on Behalf of Symbotic Inc. (SYM) Investors Who Purchased Shares Prior to February 5, 2024, As Shareholder Class Action Survives Motion to Dismiss

Tue, 25 Aug 2026 08:54:00 -0400

Philadelphia, Pennsylvania--(Newsfile Corp. - August 25, 2026) - Grabar Law Office is investigating claims on behalf of investors who purchased or otherwise acquired Symbotic Inc. (NASDAQ: SYM) securities on or before February 5, 2024.

What is Happening? Key allegations of a federal securities fraud class action have survived Defendants' motion to dismiss the complaint. The investigation follows a recent federal court decision permitting significant securities fraud claims against Symbotic Inc. (NASDAQ: SYM) and its Chairman and Chief Executive Officer, Richard B. Cohen, to proceed. Specifically, on July 23, 2026, Chief Judge Denise J. Casper of the United States District Court

Grabar Law Office Investigates Claims on Behalf of Symbotic Inc. (SYM) Investors Who Purchased Shares Prior to February 5, 2024, As Shareholder Class Action Survives Motion to Dismiss

Tue, 25 Aug 2026 08:54:00 -0400

Form 144 Symbotic Inc. Filed by: Dunn Michael David

Mon, 24 Aug 2026 16:40:00 -0400

si-local-file:///var/storage/secattach/20260824/26968690.html

Form 144 Symbotic Inc. Filed by: Dunn Michael David

Mon, 24 Aug 2026 16:40:00 -0400

si-local-file:///var/storage/secattach/20260824/26968690.html

Form 144 Symbotic Inc. Filed by: Kuffner James

Mon, 24 Aug 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260824/26968624.html

Form 144 Symbotic Inc. Filed by: Kuffner James

Mon, 24 Aug 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260824/26968624.html

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Roblox Corporation (NYSE: RBLX); Symbotic Inc. (NASDAQ: SYM); and The Simply Good Foods Company (NASDAQ: SMPL):

Mon, 24 Aug 2026 08:03:30 -0400

PHILADELPHIA, Aug. 24, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Roblox Corporation (NYSE: RBLX); Symbotic Inc. (NASDAQ: SYM); and The Simply Good Foods Company (NASDAQ: SMPL):

Mon, 24 Aug 2026 08:03:30 -0400

PHILADELPHIA, Aug. 24, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Roblox Corporation (NYSE: RBLX); Symbotic Inc. (NASDAQ: SYM); and The Simply Good Foods Company (NASDAQ: SMPL):

Mon, 24 Aug 2026 08:03:30 -0400

PHILADELPHIA, Aug. 24, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Roblox Corporation (NYSE: RBLX); Symbotic Inc. (NASDAQ: SYM); and The Simply Good Foods Company (NASDAQ: SMPL):

Mon, 24 Aug 2026 08:03:30 -0400

PHILADELPHIA, Aug. 24, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Roblox Corporation (NYSE: RBLX); Symbotic Inc. (NASDAQ: SYM); and The Simply Good Foods Company (NASDAQ: SMPL):

Mon, 24 Aug 2026 08:03:30 -0400

PHILADELPHIA, Aug. 24, 2026 (GLOBE NEWSWIRE) --

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY):

Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY).

What is The Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.

If you purchased ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares prior to March 9, 2026, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award